Berberine promotes M2 macrophage polarisation through the IL-4-STAT6 signalling pathway in ulcerative colitis treatment
Aim: This study focusses on the anti-inflammatory and immune-modulatory roles of berberine (BBR) in ulcerative colitis (UC) treatment. Additionally, the underlying mechanisms of BBR were systematically explored. Methods: A 3% (w/v) dextran sodium sulphate (DSS) solution was used for establishing the...
Main Authors: | Kai Xiong, Jia Deng, Tinghui Yue, Wenting Hu, Xinglin Zeng, Tao Yang, Tianbao Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S240584402301383X |
Similar Items
-
Berberine inhibits IFN-γ signaling pathway in DSS-induced ulcerative colitis
by: Tao Yang, et al.
Published: (2022-06-01) -
Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis
by: Deng J, et al.
Published: (2020-06-01) -
Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy
by: Cuipeng Zhu, et al.
Published: (2022-12-01) -
Berberine Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis and Inhibits the Secretion of Gut Lysozyme via Promoting Autophagy
by: Xiaofan Xu, et al.
Published: (2022-07-01) -
Berberine-loaded PLGA nanoparticles alleviate ulcerative colitis by targeting IL-6/IL-6R axis
by: Chao Liu, et al.
Published: (2024-10-01)